Selected research
Industry Research
Atracurium Besylate Injection Industry Research Report 2026
Market perspective
The global Atracurium Besylate Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Atracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Atracurium Besylate Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Atracurium Besylate Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Atracurium Besylate Injection include Qilu Pharma, Pfizer, Hengrui Medicine, GSK, SGPharma, Samarth Life Sciences, Lexicare Pharma, HBM Pharma and Gland Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Atracurium Besylate Injection market in terms of revenue (US$ million) and, where applicable, sales volume (L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/L) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Atracurium Besylate Injection Market by Company
Qilu Pharma
Pfizer
Hengrui Medicine
GSK
SGPharma
Samarth Life Sciences
Lexicare Pharma
HBM Pharma
Gland Pharma
Flagship Biotech
Centurion Healthcare
American Remedies Healthcare
Atracurium Besylate Injection Segment by Type
2.5ml:12.5mg
5ml:25mg
Atracurium Besylate Injection Segment by Application
Surgery
Medical Examination
Atracurium Besylate Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atracurium Besylate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Atracurium Besylate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atracurium Besylate Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Atracurium Besylate Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Atracurium Besylate Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Atracurium Besylate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2.5ml:12.5mg
- 5ml:25mg
Applications
- Surgery
- Medical Examination
Companies covered
- Qilu Pharma
- Pfizer
- Hengrui Medicine
- GSK
- SGPharma
- Samarth Life Sciences
- Lexicare Pharma
- HBM Pharma
- Gland Pharma
- Flagship Biotech
- Centurion Healthcare
- American Remedies Healthcare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Atracurium Besylate Injection Market Size (2021-2032)
- 2.2.2 Global Atracurium Besylate Injection Sales (2021-2032)
- 2.2.3 Global Atracurium Besylate Injection Market Average Price (2021-2032)
- 2.3 Atracurium Besylate Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 2.5ml:12.5mg
- 2.3.3 5ml:25mg
- 2.4 Atracurium Besylate Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Surgery
- 2.4.3 Medical Examination
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Atracurium Besylate Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Atracurium Besylate Injection Sales (L) of Manufacturers (2021-2026)
- 3.3 Global Atracurium Besylate Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Atracurium Besylate Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Atracurium Besylate Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Atracurium Besylate Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Atracurium Besylate Injection, Product Type & Application
- 3.8 Global Manufacturers of Atracurium Besylate Injection, Established Date
- 3.9 Global Atracurium Besylate Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Qilu Pharma
- 4.1.1 Qilu Pharma Company Information
- 4.1.2 Qilu Pharma Business Overview
- 4.1.3 Qilu Pharma Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Qilu Pharma Atracurium Besylate Injection Product Portfolio
- 4.1.5 Qilu Pharma Recent Developments
- 4.2 Pfizer
- 4.2.1 Pfizer Company Information
- 4.2.2 Pfizer Business Overview
- 4.2.3 Pfizer Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer Atracurium Besylate Injection Product Portfolio
- 4.2.5 Pfizer Recent Developments
- 4.3 Hengrui Medicine
- 4.3.1 Hengrui Medicine Company Information
- 4.3.2 Hengrui Medicine Business Overview
- 4.3.3 Hengrui Medicine Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hengrui Medicine Atracurium Besylate Injection Product Portfolio
- 4.3.5 Hengrui Medicine Recent Developments
- 4.4 GSK
- 4.4.1 GSK Company Information
- 4.4.2 GSK Business Overview
- 4.4.3 GSK Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GSK Atracurium Besylate Injection Product Portfolio
- 4.4.5 GSK Recent Developments
- 4.5 SGPharma
- 4.5.1 SGPharma Company Information
- 4.5.2 SGPharma Business Overview
- 4.5.3 SGPharma Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 SGPharma Atracurium Besylate Injection Product Portfolio
- 4.5.5 SGPharma Recent Developments
- 4.6 Samarth Life Sciences
- 4.6.1 Samarth Life Sciences Company Information
- 4.6.2 Samarth Life Sciences Business Overview
- 4.6.3 Samarth Life Sciences Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Samarth Life Sciences Atracurium Besylate Injection Product Portfolio
- 4.6.5 Samarth Life Sciences Recent Developments
- 4.7 Lexicare Pharma
- 4.7.1 Lexicare Pharma Company Information
- 4.7.2 Lexicare Pharma Business Overview
- 4.7.3 Lexicare Pharma Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Lexicare Pharma Atracurium Besylate Injection Product Portfolio
- 4.7.5 Lexicare Pharma Recent Developments
- 4.8 HBM Pharma
- 4.8.1 HBM Pharma Company Information
- 4.8.2 HBM Pharma Business Overview
- 4.8.3 HBM Pharma Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 HBM Pharma Atracurium Besylate Injection Product Portfolio
- 4.8.5 HBM Pharma Recent Developments
- 4.9 Gland Pharma
- 4.9.1 Gland Pharma Company Information
- 4.9.2 Gland Pharma Business Overview
- 4.9.3 Gland Pharma Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Gland Pharma Atracurium Besylate Injection Product Portfolio
- 4.9.5 Gland Pharma Recent Developments
- 4.10 Flagship Biotech
- 4.10.1 Flagship Biotech Company Information
- 4.10.2 Flagship Biotech Business Overview
- 4.10.3 Flagship Biotech Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Flagship Biotech Atracurium Besylate Injection Product Portfolio
- 4.10.5 Flagship Biotech Recent Developments
- 4.11 Centurion Healthcare
- 4.11.1 Centurion Healthcare Company Information
- 4.11.2 Centurion Healthcare Business Overview
- 4.11.3 Centurion Healthcare Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Centurion Healthcare Atracurium Besylate Injection Product Portfolio
- 4.11.5 Centurion Healthcare Recent Developments
- 4.12 American Remedies Healthcare
- 4.12.1 American Remedies Healthcare Company Information
- 4.12.2 American Remedies Healthcare Business Overview
- 4.12.3 American Remedies Healthcare Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 American Remedies Healthcare Atracurium Besylate Injection Product Portfolio
- 4.12.5 American Remedies Healthcare Recent Developments
5 Global Atracurium Besylate Injection Market Scenario by Region
- 5.1 Global Atracurium Besylate Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Atracurium Besylate Injection Sales by Region: 2021-2032
- 5.2.1 Global Atracurium Besylate Injection Sales by Region: 2021-2026
- 5.2.2 Global Atracurium Besylate Injection Sales by Region: 2027-2032
- 5.3 Global Atracurium Besylate Injection Revenue by Region: 2021-2032
- 5.3.1 Global Atracurium Besylate Injection Revenue by Region: 2021-2026
- 5.3.2 Global Atracurium Besylate Injection Revenue by Region: 2027-2032
- 5.4 North America Atracurium Besylate Injection Market Facts & Figures by Country
- 5.4.1 North America Atracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Atracurium Besylate Injection Sales by Country (2021-2032)
- 5.4.3 North America Atracurium Besylate Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Atracurium Besylate Injection Market Facts & Figures by Country
- 5.5.1 Europe Atracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Atracurium Besylate Injection Sales by Country (2021-2032)
- 5.5.3 Europe Atracurium Besylate Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Atracurium Besylate Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Atracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Atracurium Besylate Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Atracurium Besylate Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Atracurium Besylate Injection Market Facts & Figures by Country
- 5.7.1 South America Atracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Atracurium Besylate Injection Sales by Country (2021-2032)
- 5.7.3 South America Atracurium Besylate Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Atracurium Besylate Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Atracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Atracurium Besylate Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Atracurium Besylate Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Atracurium Besylate Injection Sales by Type (2021-2032)
- 6.1.1 Global Atracurium Besylate Injection Sales by Type (2021-2032) & (L)
- 6.1.2 Global Atracurium Besylate Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Atracurium Besylate Injection Revenue by Type (2021-2032)
- 6.2.1 Global Atracurium Besylate Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Atracurium Besylate Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Atracurium Besylate Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Atracurium Besylate Injection Sales by Application (2021-2032)
- 7.1.1 Global Atracurium Besylate Injection Sales by Application (2021-2032) & (L)
- 7.1.2 Global Atracurium Besylate Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Atracurium Besylate Injection Revenue by Application (2021-2032)
- 7.2.1 Global Atracurium Besylate Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Atracurium Besylate Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Atracurium Besylate Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Atracurium Besylate Injection Value Chain Analysis
- 8.1.1 Atracurium Besylate Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Atracurium Besylate Injection Production Mode & Process
- 8.2 Atracurium Besylate Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Atracurium Besylate Injection Distributors
- 8.2.3 Atracurium Besylate Injection Customers
9 Global Atracurium Besylate Injection Analyzing Market Dynamics
- 9.1 Atracurium Besylate Injection Industry Trends
- 9.2 Atracurium Besylate Injection Industry Drivers
- 9.3 Atracurium Besylate Injection Industry Opportunities and Challenges
- 9.4 Atracurium Besylate Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst